Back to Research Hub
HUTCHMED (China) Limited
HCM
$10.63-0.22 (-2.03%)
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments.
StreetsValue research for HUTCHMED (China) Limited (HCM)
Members get the full report for HUTCHMED (China) Limited: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.